This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Assessment after diagnosis

Authoring team

Determining suitability for radical treatment of histologically-confirmed oesophageal or gastro-oesophageal junctional cancer after endoscopy and wholebody CT scan diagnosis

  • F-18 FDG PET-CT should be offered to people with oesophageal and gastro-oesophageal junctional tumours that are suitable for radical treatment (except for T1a tumours)

  • do not offer endoscopic ultrasound only to distinguish between T2-T3 tumours in people with oesophageal and gastro-oesophageal junctional tumours

  • endoscopic ultrasound should only be offered to people with oesophageal and gastrooesophageal junctional cancer when it will help guide ongoing management

  • staging laparoscopy should only considered for people with oesophageal or gastrooesophageal junctional cancer when it will help guide ongoing management.

HER2 testing in metastatic oesophago-gastric adenocarcinoma

  • HER2 testing should be offered to people with metastatic oesophago-gastric adenocarcinoma

Reference:

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.